The null hypothesis tested was that, assuming the cancer would acquire a KRAS mutation and one of the common alleles (found in >3% of the tumor samples for a given cancer) was sufficient, the frequency of the KRAS alleles would be determined by the mutational processes alone. The gene discussed is KRAS; the disease is neoplasm.